GOSS - Gossamer Bio, Inc.

QQQ $ 618.30 $ -6.48 (-1.04 %)

DIA $ 482.46 $ 1.90 (0.4 %)

SPY $ 681.44 $ -3.42 (-0.5 %)

TLT $ 90.13 $ 0.18 (0.2 %)

GLD $ 384.79 $ 4.64 (1.22 %)

Previous Close

$ 2.59

Open

$ 2.63

Bid

$ 2.54 x 1,704

Ask

$ 2.55 x 2,807

Day's Range

$ 2.54 - $ 2.63

52 Week Range

$ 0.66 - $ 3.60

Volume

2,300,251

Average Volume

Market Cap

599.47M

Beta (5Y Monthly)

$ 1.46

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-05-2025	09-30-2025	10-Q
2	08-05-2025	06-30-2025	10-Q
3	05-15-2025	03-31-2025	10-Q
4	03-13-2025	12-31-2024	10-K
5	11-07-2024	09-30-2024	10-Q
6	08-12-2024	06-30-2024	10-Q
7	05-07-2024	03-31-2024	10-Q
8	03-05-2024	12-31-2023	10-K
9	11-09-2023	09-30-2023	10-Q
10	08-08-2023	06-30-2023	10-Q
11	05-09-2023	03-31-2023	10-Q
12	03-17-2023	12-31-2022	10-K
13	11-03-2022	09-30-2022	10-Q
14	08-09-2022	06-30-2022	10-Q
15	05-10-2022	03-31-2022	10-Q
16	03-03-2022	12-31-2021	10-K
17	11-08-2021	09-30-2021	10-Q
18	08-09-2021	06-30-2021	10-Q
19	05-06-2021	03-31-2021	10-Q
20	02-26-2021	12-31-2020	10-K
21	11-10-2020	09-30-2020	10-Q
22	08-11-2020	06-30-2020	10-Q
23	05-12-2020	03-31-2020	10-Q
24	03-24-2020	12-31-2019	10-K
25	11-12-2019	09-30-2019	10-Q
26	08-08-2019	06-30-2019	10-Q
27	05-14-2019	03-31-2019	10-Q
28	03-22-2019	12-31-2018	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Gossamer Bio Q3 EPS $(0.21) Misses $(0.18)...
11/05/2025 21:31:41

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.18...

Gossamer Bio Enters into Option Agreement ...
09/25/2025 11:32:33

Gossamer Bio To Present At European Respir...
09/22/2025 11:37:18

Cantor Fitzgerald Reiterates Overweight on...
09/11/2025 12:32:05

Cantor Fitzgerald analyst Olivia Brayer reiterates Gossamer Bio (NASDAQ:GOSS) from Overweight to Overweight.

this-saia-analyst-turns-bullish-here-are-top-4-upgrades-for-wednesday

This Saia Analyst Turns Bullish; Here Are ...
09/10/2025 11:50:01

UBS Upgrades Gossamer Bio to Buy, Raises P...
09/10/2025 10:44:11

UBS analyst Eliana Merle upgrades Gossamer Bio (NASDAQ:GOSS) from Neutral to Buy and raises the price target from $1.25 to $9.

Wedbush Maintains Outperform on Gossamer B...
08/06/2025 15:59:14

Wedbush analyst Laura Chico maintains Gossamer Bio (NASDAQ:GOSS) with a Outperform and raises the price target from $4 to $5.

Gossamer Bio Q2 EPS $(0.17) Beats $(0.18) ...
08/05/2025 20:24:43

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.18) ...

ultragenyx-pharmaceutical-apple-and-other-big-stocks-moving-lower-in-mondays-pre-market-session

Ultragenyx Pharmaceutical, Apple And Other...
07/14/2025 12:14:56

Scotiabank Initiates Coverage On Gossamer ...
07/14/2025 11:53:08

Scotiabank analyst Greg Harrison initiates coverage on Gossamer Bio (NASDAQ:GOSS) with a Sector Outperform rating and announ...

Gossamer Bio Completes Enrollment In Phase...
06/16/2025 11:36:20

Gossamer Bio Completes Enrollment In Regis...
06/16/2025 11:33:53

Goldman Sachs Maintains Buy on Gossamer Bi...
05/16/2025 16:49:55

Goldman Sachs analyst Paul Choi maintains Gossamer Bio (NASDAQ:GOSS) with a Buy and raises the price target from $7 to $8.

Wedbush Reiterates Outperform on Gossamer ...
05/16/2025 14:02:57

Wedbush analyst Laura Chico reiterates Gossamer Bio (NASDAQ:GOSS) with a Outperform and maintains $4 price target.

Gossamer Bio Q1 EPS $(0.16) Beats $(0.18) ...
05/15/2025 20:03:05

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.18) ...

Earnings Scheduled For May 15, 2025
05/15/2025 08:32:23

Exploring Gossamer Bio's Earnings Expectat...
05/14/2025 20:07:43

Gossamer Bio To Present Preclinical Data A...
05/07/2025 20:07:00

Gossamer Bio, Inc. (NASDAQ:GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization o...

Goldman Sachs Maintains Buy on Gossamer Bi...
04/17/2025 17:38:17

Goldman Sachs analyst Paul Choi maintains Gossamer Bio (NASDAQ:GOSS) with a Buy and lowers the price target from $8 to $7.

HC Wainwright & Co. Reiterates Buy on Goss...
03/18/2025 10:37:40

HC Wainwright & Co. analyst Patrick Trucchio reiterates Gossamer Bio (NASDAQ:GOSS) with a Buy and maintains $10 price ta...